A prospective, multi-center, Phase 1b/2a study to assess the safety and tolerability of different doses ofAG019 administered alone or in association with teplizumab in subjects with clinical recent-onset Type 1Diabetes Mellitus (T1D).

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences